Search

everythinglearnresearchcommunity

for

Search:↓

Various medications and vaccines can cause serious side effects.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Follicular mucinosis in a 15-year-old is usually harmless but needs monitoring for possible lymphoma.

A group has developed therapies that show promise for treating cancer and various other conditions.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Pemphigus patients with alopecia have more severe and treatment-resistant disease.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.